Clinical Trial Update: Two Separate But Identical Studies Evaluating the Safety and Efficacy of ALTROPANE® in the Use of SPECT Imaging for Upper Extremity Tremor [Phase 3]

View source ↗

Summary

Two Phase 3 studies are evaluating ALTROPANE for SPECT imaging of upper-extremity tremor in Parkinsonian syndromes; the current status of the trials is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Parkinsonian Syndromes

Drugs mentioned

• Altropane (Altropane)

Snippet

Sponsor: Alseres Pharmaceuticals, Inc | Conditions: Parkinsonian Syndromes | Phase 3 | Status: UNKNOWN